Skip to main content
. 2022 Aug 22;39(10):4808–4820. doi: 10.1007/s12325-022-02248-5

Table 1.

Treatment received by patients with wet AMD and treatment settings

Participants n = 466 (%)
Treatment name
 Bevacizumab 23
 Aflibercept 33
 Ranibizumab 37
 Other anti-VEGF agents 7
Treatment setting
 Outpatient–large practice with ≥ 6 ophthalmologists 62
 Outpatient–small practice with ≤ 5 ophthalmologists 18
 Outpatient clinic with 1 ophthalmologist 5
 Mobile ophthalmology clinics < 1
 Hospital/academic/university centre 14